Manual Review Required

EGFR mutation

solid tumor basket · Immune Checkpoint Inhibitor

EGFR mutation is flagged as manual review required because public trials show inclusion required evidence in 8 contexts. FDA CDx context should be reviewed manually.

Role evidence

Usage summary

Strongest role: Inclusion Required

Inclusion-required count: 5

Treatment-assignment count: 0

Stratification count: 0

Threshold snippets

Fragmentation view

Threshold count: 2

Common snippets: MET exon 14 skipping | MSI-H

Threshold label: Moderate

FDA CDx context

Mapping summary

CDx label: Fda Cdx Context Manual Review Required

CDx maturity score: 2/5

Confidence: Low

Patent-density signal

Diagnostic appendix

Signal count: 0

Recent signals: 0

Density label: Low

Source links

Evidence paths

https://clinicaltrials.gov/study/NCT03371381 | https://clinicaltrials.gov/study/NCT02973997 | https://clinicaltrials.gov/study/NCT03065764 | https://clinicaltrials.gov/study/NCT03680521 | https://clinicaltrials.gov/study/NCT05063552 | https://clinicaltrials.gov/study/NCT07469774 | https://clinicaltrials.gov/study/NCT05419817 | https://clinicaltrials.gov/study/NCT05584670